Endgame Take 2 - Transhumanism, Autonotoms, and Such
Spiraling down into the tech-driven genocide and global slavery.
Continued from “Endgame Behind Covid-19 mRNA Vaccines?“
OK, we’ll make a lot of progress today toward understanding what is going on with our world, if not so much who exactly is behind it. Let’s get straight to it.
If you thought that two-way computer-brain communication is sci-fi stuff, now you won’t. Here are just few reviews and articles on the subject (older first). The company Bettelle is mentioned in three of them, winning the contract with DARPA and progressing to Phase II in 2020!
2017.05.22 “Syringe-injectable mesh electronics integrate seamlessly with minimal chronic immune response in the brain” “Seamless integration of electrical probes within neural tissue could substantially enhance their impact and open up new opportunities in neuroscience research through electronic therapeutics. This paper describes systematic studies of brain tissue behavior following implantation of a design for probes that can be precisely targeted to specific brain regions by syringe injection as in many biological species and have an ultraflexible open mesh structure similar to brain tissue itself. Studies of the chronic tissue response postimplantation demonstrate that these tissue-like probes do not elicit inflammation or scarring, in contrast to more conventional probes. Moreover, neurons were found to penetrate through the probes’ open mesh structure, thus demonstrating an unprecedented level of integration and compatibility with the brain circuitry.“
2019.03.29 (Elon Musk) “Human Brain/Cloud Interface” “A “human brain/cloud interface” (“B/CI”), would be based on technologies referred to here as “neuralnanorobotics.” Future neuralnanorobotics technologies are anticipated to facilitate accurate diagnoses and eventual cures for the ∼400 conditions that affect the human brain. Neuralnanorobotics may also enable a B/CI with controlled connectivity between neural activity and external data storage and processing, via the direct monitoring of the brain’s ∼86 × 109 neurons and ∼2 × 1014 synapses. Subsequent to navigating the human vasculature, three species of neuralnanorobots (endoneurobots, gliabots, and synaptobots) could traverse the blood–brain barrier (BBB), enter the brain parenchyma, ingress into individual human brain cells, and autoposition themselves at the axon initial segments of neurons (endoneurobots), within glial cells (gliabots), and in intimate proximity to synapses (synaptobots). They would then wirelessly transmit up to ∼6 × 1016 bits per second of synaptically processed and encoded human–brain electrical information via auxiliary nanorobotic fiber optics (30 cm3) with the capacity to handle up to 1018 bits/sec and provide rapid data transfer to a cloud based supercomputer for real-time brain-state monitoring and data extraction.”
2019.05.21 “Battelle wins DARPA contract for injectable brain control technology“ “A team led by US science and technology development firm Battelle has won a contract from the Defense Advanced Research Projects Agency (DARPA) for its next-generation non-surgical neurotechnology (N3) programme, aimed at developing bi-directional brain control technology interfaces for able-bodied service members. … Battelle’s N3 concept involves the development of a nano-transducer that could be introduced into the body via injection and directed to a specific area of the brain to help complete a task through communication with a helmet-based transceiver. … After the brain completes a task, the nano-transducer will be magnetically guided out of the brain and into the bloodstream to be taken out of the body. [Yeah, right!] The nano-transducer would use magnetoelectric nanoparticles to establish a communication channel with the brain. The magnetic core of the nano-transducers would convert the neural electrical signals into magnetic signals that would be sent through the skull to the helmet-based transceiver worn by the user.
The transceiver would also send magnetic signals back to the nano-transducers to be converted to electrical impulses capable of being processed by the neurons.”
2019.06.05 “DARPA’s New Project Is Investing Millions in Brain-Machine Interface Tech” “With the Next-Generation Nonsurgical Neurotechnology (N3) program, DARPA is looking to expand BMIs to the military. This month, the project tapped six academic teams to engineer radically different BMIs to hook up machines to the brains of able-bodied soldiers. The goal is to ditch surgery altogether—while minimizing any biological interventions—to link up brain and machine. Rather than microelectrodes, which are currently surgically inserted into the brain to hijack neural communication, the project is looking to acoustic signals, electromagnetic waves, nanotechnology, genetically-enhanced neurons, and infrared beams for their next-gen BMIs.”
2020.02.20 “The Brain-Machine Interface & Syringe-injectable Mesh - A highest-stakes game” "In the not too distant future, we posit that our level of technological and scientific insight will be sufficient to stably interface with the human brain in a manner that mirrors the organization of the brain itself."
2020.12.15 “Battelle Neuro Team Advances to Phase II of DARPA N3 Program“: “employs magnetoelectric nanotransducers (MEnTs) localized in neural tissue for BCI applications. One of the key MEnT attributes are their incredibly small size—thousands of MEnTs can fit across the width of a human hair. The MEnTs are first injected into the circulatory system and then guided with a magnet to the targeted area of the brain. “Our current data suggests that we can non-surgically introduce MEnTs into the brain for subsequent bi-directional neural interfacing,” said Patrick Ganzer, a Battelle researcher and the principal investigator on the project.
Several technology development goals and N3 program metrics were achieved during Phase 1, such as precise reading and writing to neurons using this breakthrough technology, leveraging the multi-modal expertise of the BrainSTORMS team across the domains of electromagnetics, nanoscale materials, and neurophysiology. Phase 2 efforts will focus on maturing the capability sets of the MEnTs for writing information to the brain and advancing the construction and testing of the external writing interface.“
2021.09.02 “Separating science from sci-fi: Battelle's Justin Sanchez on balancing the buzz of brain-computer interfaces“: “That fundamental technology has since been expanded into stroke rehabilitation and, through Battelle’s long-running partnership with the U.S. Defense Advanced Research Projects Agency—where Sanchez was previously director of the biological technologies office—the ongoing development of a noninvasive brain-computer interface that involves an external headset and injected nanoparticles for neural stimulation. … Justin Sanchez: For a number of years, going back to 2013, 2014, we have developed neural interfaces to both the brain and the body that can detect when the brain and nerves and muscles are becoming active. We’ve got algorithms that can interpret that information in real time, and we can use it to do remarkable things like reanimate a limb after a person has been paralyzed—or we can use it even beyond the medical sense, in sports applications or entertainment applications.” As you may have noticed, Bettelle has been progressing so well with their technology that in Sep. 2021 they felt obliged to active play down the progress made, lest it invokes too much attention, but still couldn’t stop boasting.
2021.11.18 “Blackrock Neurotech nabs FDA breakthrough nod for system that uses thoughts to control devices“ “Blackrock will be competing against Synchron to become the first to receive approval for an implanted brain-computer interface. The latter company got the FDA’s go-ahead in July to begin clinical trials of its Stentrode device, which is inserted in the jugular vein to gather neurological signals that are then used to control a computer mouse and keyboard.“ They note that “Blackrock—which is unrelated to investment firm BlackRock—is already working on a next-generation version of the interface that’s even smaller and completely wireless.”
And the winner is: brain-computer interface that involves an external headset and injected nanoparticles.
Based on the presented information, it seems that injectable nanoparticles that traverse blood-brain barier already can be and are being used (Phase II at least) for mind monitoring and control. This brings me back to my article about the graphene quantum dots (GQDs) in the Pfizer mRNA vaccine.
Another curious fact is this. Moncef Slaoui, Head of Operation Warp Speed from May 15, 2020 till January 12, 2021, has been intimately involved with this industry. In 2016 he was named to the inaugural board of directors of Galvani Bioelectronics, the joint venture between GSK and Alphabet Corporation subsidiary Verily Life Sciences. Read this in the aricle from Aug. 2017, “Electroceuticals: the 'bonkers' gamble that could pay off for GlaxoSmithKline“: “A year after GSK teamed up with Google’s parent company, Alphabet, to set up Galvani Bioelectronics, Kris Famm, who runs the venture, is confident that an implantable device capable of altering electrical impulses in the body is within reach.”
This information puts the Microsoft Patent WO2020060606A1 from 2018, “Cryptocurrency system using body activity data“ in totally new light. It seems to clearly describe the mind control apparatus in action, where the “slaves” (a.k.a. autonotoms) perform the actions dictated to them by the “master”, in computer parlance. Here’s the best transhumanism application they could come up with. How benevolent!
It seems like the total vaccination campaign may be pursuing simultaneously more than one goal:
doing away with bodily autonomy (humans treated like cattle)
preparing grounds for the injectables that will monitor and control injectee’s thoughts (and movements?)
After people agree to accept any and all injections, for their own good, of course, there will be nothing left to stop the administration of mind controlling injectables. Welcome to the ultimate slavery, those of us still around.
If you think these conclusions are too far-fetched, listen to this interview with Catherine Austin Fitts for “Planet Lockdown”, Jan. 6, 2021. Or this interview with her from Nov. 18, 2021. This will help you put things in perspective.
P.S. On the coattails of my article: 2021.12.21 “FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention“ from GSK, “for use in at-risk adults and ???adolescents weighing at least 35 kilograms???” How old are the adolescents @35kg (77lb)?